NCT05821868View on ClinicalTrials.gov

Contrasting Dosivent With Plus Flow Vu Spacer in Bronchial Hyperreactivity Participants

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

July 1, 2023

Study Completion Date

September 1, 2023

Conditions
Bronchial HyperreactivityInhalant Use
Interventions
DEVICE

Dosivent

Dosivent® inhalation chamber is designed to optimize the delivery of inhaled bronchodilators and corticosteroids in the treatment of respiratory diseases

DEVICE

Aerochamber Plus Flow Vu

Aerochamber Plus Flow Vu® inhalation chamber is also designed to optimize the delivery of inhaled bronchodilators and corticosteroids in the treatment of respiratory diseases

Trial Locations (1)

28007

Hospital General Universitario Gregorio Marañon, Madrid

All Listed Sponsors
lead

Hospital General Universitario Gregorio Marañon

OTHER